News Search Results
Oct 08, 2024, 07:00 ET Emmecell Completes Last Patient Last Visit for Proof-of-Concept Trial of Groundbreaking Cell Therapy for Corneal Edema
without surgery would be a game-changer for patients suffering with corneal edema," said Ellen Koo, MD, professor of ophthalmology at the Bascom Palmer Eye Institute, University of Miami, and an investigator in the study. "Currently, for patients
More news about: Emmecell
Oct 07, 2024, 17:20 ET AI is Redefining the Disposable Hospital Supplies Market, Projected to Grow by USD 24.5 Billion from 2024 to 2028 Amid Rising Hospitalizations
and waste management solutions is expected to grow significantly in the coming years. Key applications include cardiovascular, cerebrovascular, ophthalmology, gynecology, urology, and orthopedics. The market is fragmented, with major players focusing on innovation, product quality, and cost competitiveness.
More news about: Technavio
Oct 07, 2024, 08:30 ET Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
clinical operations where she managed biomarker strategies for global trials across a diverse range of therapeutic areas, including Oncology and Ophthalmology. Ms Gupta is a dedicated leader in inclusive research, advancing multiple initiatives to bolster diverse patient recruitment at Genentech. She holds
More news about: Anixa Biosciences, Inc.
Oct 07, 2024, 07:45 ET New Data Demonstrate Substantial Therapeutic Potential of Capsida's IV Gene Therapy for Parkinson's Disease Associated with GBA Mutations
programs, the Company has validating CNS partnerships with AbbVie, Lilly, CRISPR Therapeutics, and the AbbVie partnership was expanded to include ophthalmology disorders. Capsida was founded in 2019 by lead investors Versant Ventures and Westlake Village BioPartners and originated from groundbreaking research
More news about: Capsida Biotherapeutics
Oct 07, 2024, 06:00 ET NTC Launches Imperial, the new eye drops product line on THE PATIENT'S SIDE
portfolio, pursuing maximum patient satisfaction and compliance", says Marcello Selvaggio, NTC Global Head Ophthalmology. "We launched the Imperial product line for dry eye offering to our partners a solution that blends the benefits of the other main multidose preservative
More news about: NTC Pharma
Oct 07, 2024, 06:00 ET NTC Launches Imperial, the new eye drops product line on THE PATIENT'S SIDE
portfolio, pursuing maximum patient satisfaction and compliance", says Marcello Selvaggio, NTC Global Head Ophthalmology. "We launched the Imperial product line for dry eye offering to our partners a solution that blends the benefits of the other main multidose preservative
More news about: NTC Pharma
Oct 07, 2024, 06:00 ET LG Display Introduces the World's First Eyesafe® Circadian Displays
world-class team of eye doctors, engineers, and scientists with decades of experience in electronics, display materials, light management, optometry, and ophthalmology. The Eyesafe brand is trusted by consumers and integrated in millions of digital devices from Dell, HP, Lenovo, LG, ZAGG and more. Eyesafe is recognized
More news about: Eyesafe
Oct 07, 2024, 06:00 ET NTC bringt Imperial auf den Markt, die neue Augentropfen-Produktlinie von THE PATIENT'S SIDE
und streben nach maximaler Patientenzufriedenheit und Compliance", sagt Marcello Selvaggio, NTC Global Head Ophthalmology. „Wir haben die Imperial-Produktlinie für trockene Augen auf den Markt gebracht, um unseren Partnern eine Lösung zu bieten, die die Vorteile der
More news about: NTC Pharma
Oct 07, 2024, 06:00 ET NTC lance Imperial, la nouvelle gamme de collyres du côté du patient
recherchant une satisfaction et une conformité maximales des patients », déclare Marcello Selvaggio, NTC Global Head Ophthalmology. « Nous avons lancé la ligne de produits Imperial pour la sécheresse oculaire en offrant à nos partenaires une solution qui combine les avantages
More news about: NTC Pharma
Oct 04, 2024, 09:00 ET Top Companies, Marketers, CEOs, Products, and Initiatives Were Celebrated During Trailblazer Gala on October 1st
Katie Lewandroski, Executive Director, Oncology Marketing Lead (Sumitomo Pharma America, Inc.)Ophthalmology/Optometry: Liz Tempesta, Senior Director, Consumer Marketing, Eye Care Division (Viatris)OTC Marketer:
More news about: PM360
Oct 04, 2024, 06:48 ET Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme, 'Building Resilience for a Sustainable Tomorrow'
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Ltd
Oct 04, 2024, 06:43 ET Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme, 'Building Resilience for a Sustainable Tomorrow'
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Ltd
Oct 02, 2024, 11:01 ET Regenerative Medicine Market to Reach $37.27 Billion by 2031, Driven by the Growing Number of New Regenerative Medicine Approvals and Consistent Advancements in the Regenerative Medicine Space - Exclusive Report by Meticulous Research®
Analysis by Product (Gene Therapy, Stem Cell, Tissue Engineering), Application (Musculoskeletal, Cancer, Cardiovascular, Immunology, Dermatology, Ophthalmology), End User—Global Forecast to 2031.
More news about: Meticulous Market Research Pvt. Ltd.
Oct 02, 2024, 11:00 ET NIH Award Supports Cerebral Small Vessel Disease Detection Through the Eye
Hong Jiang, M.D., Ph.D., a professor of clinical ophthalmology and neurology, who will conduct the screening and clinical efforts; Felipe Medeiros, M.D., Ph.D., professor of ophthalmology and Bascom Palmer's vice-chair of research, who will provide expertise
More news about: Bascom Palmer Eye Institute
Oct 02, 2024, 11:00 ET NYU Langone Awarded $1.6 Million to Investigate Alzheimer's & Parkinson's Progression Through the Eye
Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, MD, Professor of Ophthalmology and chair of the Department of Ophthalmology. "Dr. Srinivasan and Dr. Balcer are leaders in advancing the emerging science of oculomics, and it's thrilling to see this
More news about: NYU Langone Health
Oct 02, 2024, 02:19 ET Science and Technology Daily: From Ancient Wisdom to Modern Marvels
benefited the world. Dr. Saulebek Kabylbekov, an ophthalmologist from Kazakhstan who has been at the Daqing Ophthalmology Hospital, Heilongjiang province, for 25 years, believes the BRI fosters collaboration and development among nations.
More news about: Science and Technology Daily
Oct 01, 2024, 10:00 ET Kemin Highlights Groundbreaking Study on FloraGLO® Lutein and OPTISHARP™ Natural Zeaxanthin for Maternal and Infant Health
mothers and their newborn infants. Published in the September 2024 issue of Ophthalmology Science, an official journal of the American Academy of Ophthalmology, this study emphasizes the potential of these carotenoids in supporting both mothers and their infants.
More news about: Kemin Industries
Oct 01, 2024, 09:50 ET Eyemart Express Turns Its Focus to Vision Protection for Eye Injury Prevention Month
American Academy of Ophthalmology. "Wearing proper protective eyewear is one of the simplest ways to avoid serious damage to your vision," says
More news about: Eyemart Express
Oct 01, 2024, 09:00 ET Zenni and Chase Stokes Team Up for Mental Health: Announcing Donation with Bring Change to Mind
A study by Orbis published in Ophthalmology reveals that children with vision impairments, affecting an estimated 70 million globally, face higher rates of anxiety and depression compared
More news about: Zenni Optical
Oct 01, 2024, 07:00 ET InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
More news about: InMode LTD
Sep 30, 2024, 11:30 ET Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics/bio-therapeutics
More news about: Piramal Pharma Solutions
Sep 30, 2024, 10:35 ET Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics/bio-therapeutics
More news about: Piramal Pharma Solutions
Sep 30, 2024, 08:05 ET Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting
https://www.cdc.gov/vision-health/about-eye-disorders/11 American Academy of Ophthalmology (2024) Access from:
More news about: Johnson & Johnson
Sep 30, 2024, 03:00 ET Honda Prize 2024 Awarded to Dr. James G. Fujimoto of U.S.
of optical coherence tomography (OCT). The prize also acknowledges his contribution to the commercialization and clinical translation of OCT in ophthalmology, cardiology, and biomedical research. Image1:
More news about: Honda Foundation
Sep 27, 2024, 10:30 ET AMD Drugs Market to Hit USD 17.37 Billion by 2029 with 10.7% CAGR | MarketsandMarkets™
cardiovascular, renal, metabolic, immunology, neuroscience, ophthalmology, and oncology. In 2023, Novartis became a pure-play innovative medicines company by spinning off its Sandoz generic and biosimilar business unit. The company strongly focuses on ophthalmology, and markets FDA-approved drugs like Lucentis and
More news about: MarketsandMarkets